Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Non-Current Assets (2016 - 2025)

Bioceres Crop Solutions' Non-Current Assets history spans 7 years, with the latest figure at $363.6 million for Q2 2024.

  • For Q2 2024, Non-Current Assets fell 13.62% year-over-year to $363.6 million; the TTM value through Jun 2024 reached $363.6 million, down 13.62%, while the annual FY2024 figure was $363.6 million, 13.62% down from the prior year.
  • Non-Current Assets for Q2 2024 was $363.6 million at Bioceres Crop Solutions, down from $420.9 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $420.9 million in Q2 2023 and bottomed at $102.4 million in Q2 2020.
  • The 4-year median for Non-Current Assets is $273.4 million (2021), against an average of $267.5 million.
  • The largest annual shift saw Non-Current Assets skyrocketed 78.85% in 2021 before it decreased 13.62% in 2024.
  • A 4-year view of Non-Current Assets shows it stood at $102.4 million in 2020, then surged by 78.85% to $183.1 million in 2021, then surged by 129.9% to $420.9 million in 2023, then fell by 13.62% to $363.6 million in 2024.
  • Per Business Quant, the three most recent readings for BIOX's Non-Current Assets are $363.6 million (Q2 2024), $420.9 million (Q2 2023), and $183.1 million (Q2 2021).